[1]
I. M. N. G. Sabudi and A. Z. . Hendri, “Risk factors of doxorubicin-induced cardiomyopathy in non-muscle- invasive bladder cancer”, Univ Med, vol. 43, no. 3, pp. 297–303, Nov. 2024.